tsh biopharmoration Ltd Cash Flow Quality Index
tsh biopharmoration Ltd cash flow quality index. tsh biopharmoration Ltd (8432) has a Cash Flow Quality Index of 1.62x as of June 2025. Operating cash flow of NT$42.55 Million exceeds net income of NT$26.20 Million, indicating high earnings quality where cash backs reported profits. See tsh biopharmoration Ltd free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of tsh biopharmoration Ltd (2017–2024)
Cash flow quality index of tsh biopharmoration Ltd from 2017 to 2024. Historical Cash Flow Quality Index for tsh biopharmoration Ltd across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore cash flow to debt ratio of tsh biopharmoration Ltd to assess how comfortably operating cash covers total debt obligations.
tsh biopharmoration Ltd Cash Flow Quality Index by Year (2017–2024)
tsh biopharmoration Ltd cash flow quality index by year from 2017 to 2024. Year-by-year earnings quality comparison for tsh biopharmoration Ltd. For the full cash flow conversion analysis, see cash flow conversion of tsh biopharmoration Ltd.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.62x | NT$183.77 Million | NT$113.09 Million | ▲ +265.0% |
| 2023 | 0.45x | NT$33.87 Million | NT$76.09 Million | ▲ +5.3% |
| 2022 | 0.42x | NT$34.35 Million | NT$81.24 Million | ▼ -62.1% |
| 2021 | 1.12x | NT$68.71 Million | NT$61.55 Million | ▲ +642.5% |
| 2020 | 0.15x | NT$11.61 Million | NT$77.23 Million | ▼ -85.5% |
| 2019 | 1.04x | NT$88.65 Million | NT$85.33 Million | ▼ -4.1% |
| 2018 | 1.08x | NT$62.62 Million | NT$57.78 Million | ▼ -13.2% |
| 2017 | 1.25x | NT$81.13 Million | NT$64.97 Million | — |